Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Excess mortality related to circulatory system diseases and diabetes mellitus among Italian AIDS patients vs. non-AIDS population: a population-based cohort study using the multiple causes-of-death approach

Authors: Barbara Suligoi, Saverio Virdone, Martina Taborelli, Luisa Frova, Enrico Grande, Francesco Grippo, Marilena Pappagallo, Vincenza Regine, Lucia Pugliese, Diego Serraino, Antonella Zucchetto

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Chronic diseases, chiefly cancers and circulatory system diseases (CSDs), have become the leading non-AIDS-related causes of death among HIV-infected people, as in the general population. After our previous report of an excess mortality for several non-AIDS-defining cancers, we now aim to assess whether people with AIDS (PWA) experience also an increased mortality for CSDs and diabetes mellitus (DM), as compared to the non-AIDS general population (non-PWA).

Methods

A nationwide, population-based, retrospective cohort study was conducted including 5285 Italians, aged 15−74 years, who were diagnosed with AIDS between 2006 and 2011. Multiple cause-of-death (MCoD) data, i.e. all conditions reported in death certificates, were retrieved through record-linkage with the National Register of Causes of Death up to 2011. Using MCoD data, sex- and age-standardized mortality ratios (SMRs) with 95% confidence intervals (CIs) were calculated by dividing the observed number of PWA reporting a specific disease among MCoD to the expected number, estimated on the basis of mortality rates (based on MCoD) of non-PWA.

Results

Among 1229 deceased PWA, CSDs were mentioned in 201 (16.4%) certificates and DM in 46 (3.7%) certificates among the various causes of death. These values corresponded to a 13-fold higher mortality related to CSDs (95% CI 10.8–14.4) and DM (95% CI: 9.5–17.4) as compared to 952,019 deceased non-PWA. Among CSDs, statistically significant excess mortality emerged for hypertension (23 deaths, SMR = 6.3, 95% CI: 4.0–9.4), ischemic heart diseases (39 deaths, SMR = 6.1, 95% CI: 4.4–8.4), other forms of heart diseases (88 deaths, SMR = 13.4, 95% CI: 10.8–16.5), and cerebrovascular diseases (42 deaths, SMR = 13.4, 95% CI: 9.7–18.2). The SMRs were particularly elevated among PWA aged < 50 years and those infected through drug injection.

Conclusions

The use of MCoD data disclosed the fairly high mortality excess related to several CSDs and DM among Italian PWA as compared to non-PWA. Study findings also indicate to start preventive strategies for such diseases at a younger age among AIDS patients than in the general population and with focus on drug users.
Literature
1.
go back to reference Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50:1387–96.CrossRef Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50:1387–96.CrossRef
2.
go back to reference Hanna DB, Ramaswamy C, Kaplan RC, Kizer JR, Anastos K, Daskalakis D, et al. Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001-2012. Clin Infect Dis. 2016;63:1122–9.CrossRefPubMedPubMedCentral Hanna DB, Ramaswamy C, Kaplan RC, Kizer JR, Anastos K, Daskalakis D, et al. Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001-2012. Clin Infect Dis. 2016;63:1122–9.CrossRefPubMedPubMedCentral
3.
go back to reference Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995-2008. Infection. 2012;40:627–34.CrossRefPubMed Helleberg M, Kronborg G, Larsen CS, Pedersen G, Pedersen C, Gerstoft J, et al. Causes of death among Danish HIV patients compared with population controls in the period 1995-2008. Infection. 2012;40:627–34.CrossRefPubMed
4.
go back to reference Schwarcz SK, Vu A, Hsu LC, Hessol NA. Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011. AIDS patients care. 2014;28:517–23.CrossRef Schwarcz SK, Vu A, Hsu LC, Hessol NA. Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011. AIDS patients care. 2014;28:517–23.CrossRef
5.
go back to reference Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:a:D): a multicohort collaboration. Lancet. 2014;384:241–8.CrossRefPubMed Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:a:D): a multicohort collaboration. Lancet. 2014;384:241–8.CrossRefPubMed
6.
go back to reference Vandenhende MA, Roussillon C, Henard S, Morlat P, Oksenhendler E, Aumaitre H, et al. Cancer-related causes of death among HIV-infected patients in France in 2010: evolution since 2000. PLoS One. 2015;10:e0129550.CrossRefPubMedPubMedCentral Vandenhende MA, Roussillon C, Henard S, Morlat P, Oksenhendler E, Aumaitre H, et al. Cancer-related causes of death among HIV-infected patients in France in 2010: evolution since 2000. PLoS One. 2015;10:e0129550.CrossRefPubMedPubMedCentral
7.
go back to reference Grande E, Zucchetto A, Suligoi B, Grippo F, Pappagallo M, Virdone S, et al. Multiple cause-of-death data among people with AIDS in Italy: a nationwide cross-sectional study. Popul Health Metrics. 2017;15:19. Grande E, Zucchetto A, Suligoi B, Grippo F, Pappagallo M, Virdone S, et al. Multiple cause-of-death data among people with AIDS in Italy: a nationwide cross-sectional study. Popul Health Metrics. 2017;15:19.
8.
go back to reference Zucchetto A, Virdone S, Taborelli M, Grande E, Camoni L, Pappagallo M, et al. Non-AIDS-Defining Cancer Mortality: Emerging Patterns in the Late HAART Era. J Acquir Immune Defic Syndr. 2016;73:190–6. Zucchetto A, Virdone S, Taborelli M, Grande E, Camoni L, Pappagallo M, et al. Non-AIDS-Defining Cancer Mortality: Emerging Patterns in the Late HAART Era. J Acquir Immune Defic Syndr. 2016;73:190–6.
9.
go back to reference Nduka C, Stranges S, Kimani PK, Sarki AM, Uthman OA. Is there sufficient evidence for a causal association between antiretroviral therapy and diabetes in HIV infected patients? A meta-analysis. Diabetes Metab Res Rev. 2017; https://doi.org/10.1002/dmrr.2902. [Epub ahead of print]. Nduka C, Stranges S, Kimani PK, Sarki AM, Uthman OA. Is there sufficient evidence for a causal association between antiretroviral therapy and diabetes in HIV infected patients? A meta-analysis. Diabetes Metab Res Rev. 2017; https://​doi.​org/​10.​1002/​dmrr.​2902. [Epub ahead of print].
10.
go back to reference Monroe AK, Glesby MJ, Brown TT. Diagnosing and managing diabetes in HIV-infected patients: current concepts. CID. 2015;60:453–62.CrossRef Monroe AK, Glesby MJ, Brown TT. Diagnosing and managing diabetes in HIV-infected patients: current concepts. CID. 2015;60:453–62.CrossRef
11.
12.
go back to reference Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sørensen HT, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44:1625–31.CrossRefPubMed Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sørensen HT, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44:1625–31.CrossRefPubMed
13.
go back to reference Mateen FJ, Post WS, Sacktor N, Abraham AG, Becker JT, Smith BR, et al. Long-term predictive value of the Framingham risk score for stroke in HIV-positive vs HIV-negative men. Neurology. 2013;81:2094–102.CrossRefPubMedPubMedCentral Mateen FJ, Post WS, Sacktor N, Abraham AG, Becker JT, Smith BR, et al. Long-term predictive value of the Framingham risk score for stroke in HIV-positive vs HIV-negative men. Neurology. 2013;81:2094–102.CrossRefPubMedPubMedCentral
14.
go back to reference Womack JA, Chang CC, So-Armah KA, Alcorn C, Baker JV, Brown ST, et al. HIV infection and cardiovascular disease in women. J Am Heart Assoc. 2014;3:e001035.CrossRefPubMedPubMedCentral Womack JA, Chang CC, So-Armah KA, Alcorn C, Baker JV, Brown ST, et al. HIV infection and cardiovascular disease in women. J Am Heart Assoc. 2014;3:e001035.CrossRefPubMedPubMedCentral
17.
go back to reference Whiteside YO, Selik R, An Q, Huang T, Karch D, Hernandez AL, et al. Comparison of rates of death having any death-certificate mention of heart, kidney or liver disease among persons diagnosed with HIV infection with those in the general US population, 2009-2011. Open AIDS J. 2015;9:14–22.CrossRefPubMedPubMedCentral Whiteside YO, Selik R, An Q, Huang T, Karch D, Hernandez AL, et al. Comparison of rates of death having any death-certificate mention of heart, kidney or liver disease among persons diagnosed with HIV infection with those in the general US population, 2009-2011. Open AIDS J. 2015;9:14–22.CrossRefPubMedPubMedCentral
21.
go back to reference Dal Maso L, Braga C, Franceschi S. Methodology used for "software for automated linkage in Italy" (SALI). J Biomed Inform. 2001;34:387–95.CrossRefPubMed Dal Maso L, Braga C, Franceschi S. Methodology used for "software for automated linkage in Italy" (SALI). J Biomed Inform. 2001;34:387–95.CrossRefPubMed
22.
go back to reference Breslow NE, Day NE. Statistical methods in Cancer research, volume II. The design and analysis of cohort studies. IARC scientific publications, no. 82, Lyon, France: International Agency for Research on Cancer; 1987. Breslow NE, Day NE. Statistical methods in Cancer research, volume II. The design and analysis of cohort studies. IARC scientific publications, no. 82, Lyon, France: International Agency for Research on Cancer; 1987.
23.
go back to reference Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol. 1990;131:373–5.CrossRefPubMed Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol. 1990;131:373–5.CrossRefPubMed
24.
go back to reference Savès M, Chêne G, Ducimetière P, Leport C, Le Moal G, Amouyel P, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003;37:292–8.CrossRefPubMed Savès M, Chêne G, Ducimetière P, Leport C, Le Moal G, Amouyel P, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis. 2003;37:292–8.CrossRefPubMed
25.
go back to reference Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis. 2007;45:1074–8.CrossRefPubMed Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis. 2007;45:1074–8.CrossRefPubMed
26.
go back to reference Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A. Cause-specific mortality among HIV-infected individuals, by CD4+ cell count at HAART initiation, compared with HIV-uninfected individuals. AIDS. 2014;28:257–65.CrossRefPubMedPubMedCentral Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A. Cause-specific mortality among HIV-infected individuals, by CD4+ cell count at HAART initiation, compared with HIV-uninfected individuals. AIDS. 2014;28:257–65.CrossRefPubMedPubMedCentral
28.
go back to reference Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One. 2011;6(7):e22698.CrossRefPubMedPubMedCentral Obel N, Omland LH, Kronborg G, Larsen CS, Pedersen C, Pedersen G, et al. Impact of non-HIV and HIV risk factors on survival in HIV-infected patients on HAART: a population-based nationwide cohort study. PLoS One. 2011;6(7):e22698.CrossRefPubMedPubMedCentral
29.
go back to reference Putcharoen O, Wattanachanya L, Sophonphan J, Siwamogsatham S, Sapsirisavat V, Gatechompol S, et al. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes. AIDS. 2017;31:1535–43.CrossRefPubMed Putcharoen O, Wattanachanya L, Sophonphan J, Siwamogsatham S, Sapsirisavat V, Gatechompol S, et al. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes. AIDS. 2017;31:1535–43.CrossRefPubMed
Metadata
Title
Excess mortality related to circulatory system diseases and diabetes mellitus among Italian AIDS patients vs. non-AIDS population: a population-based cohort study using the multiple causes-of-death approach
Authors
Barbara Suligoi
Saverio Virdone
Martina Taborelli
Luisa Frova
Enrico Grande
Francesco Grippo
Marilena Pappagallo
Vincenza Regine
Lucia Pugliese
Diego Serraino
Antonella Zucchetto
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3336-x

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue